Rotavirus vaccine microneedle patch - Micron Biomedical
Alternative Names: Inactivated Rotavirus Vaccine Microneedle Patch - Micron Biomedical; IRV-MNP vaccine - Micron BiomedicalLatest Information Update: 15 Jul 2025
At a glance
- Originator Micron Biomedical
- Developer Centers for Disease Control and Prevention; Micron Biomedical
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Rotavirus infections
Most Recent Events
- 09 Jul 2025 Phase-I clinical trials in Rotavirus infections (Prevention, In adults) in USA (Transdermal) (NCT06962904)
- 24 Jun 2025 Preclinical trials in Rotavirus infections in USA (Transdermal)
- 19 Jun 2025 Micron Biomedical plans a phase-I trial for Rotavirus infections (Prevention) in USA (Transdermal), (NCT06962904)